SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001842952-24-000028
Filing Date
2024-04-26
Accepted
2024-04-26 16:12:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A contexttherapeutics2024pro.htm DEFA14A 9813
2 contexttherapeuticsinc_vxn.jpg GRAPHIC 510844
3 contexttherapeuticsinc_vxna.jpg GRAPHIC 375268
  Complete submission text file 0001842952-24-000028.txt   1230935
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40654 | Film No.: 24883858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)